Neo Ivy Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $402K | Buy |
+7,556
| New | +$402K | 0.13% | 209 |
|
2022
Q4 | $0 | Buy |
+6
| New | – | ﹤0.01% | 402 |
|
2021
Q4 | – | Sell |
-1,229
| Closed | -$107K | – | 491 |
|
2021
Q3 | $107K | Buy |
+1,229
| New | +$107K | 0.12% | 236 |
|
2021
Q2 | – | Sell |
-449
| Closed | -$59K | – | 499 |
|
2021
Q1 | $59K | Buy |
+449
| New | +$59K | 0.06% | 310 |
|
2020
Q4 | – | Sell |
-1,226
| Closed | -$124K | – | 471 |
|
2020
Q3 | $124K | Sell |
1,226
-3
| -0.2% | -$303 | 0.13% | 257 |
|
2020
Q2 | $107K | Buy |
+1,229
| New | +$107K | 0.12% | 236 |
|
2020
Q1 | – | Sell |
-4,003
| Closed | -$370K | – | 481 |
|
2019
Q4 | $370K | Buy |
+4,003
| New | +$370K | 0.43% | 108 |
|
2019
Q3 | – | Sell |
-9,855
| Closed | -$1.16M | – | 318 |
|
2019
Q2 | $1.16M | Buy |
+9,855
| New | +$1.16M | 0.66% | 56 |
|